title: Diversification of HIV-1 strains after infection from a unique source.
abstract: In 1990, 7 hemophilia B patients were infected with human immunodeficiency virus type 1 (HIV-1) after exposure to a single common lot of clotting factor. The hypervariable regions V1 and V2 of the proviral env gene from the patients shared a homology between 97.5% and 100% at the time of seroconversion. To determine the in vivo diversification of these epidemiologically closely related virus strains, the patients were followed up in the early phase of HIV infection. Direct sequencing of the V1/V2 region in the env gene still revealed a very high degree of homology (96.5%-100%). In the case of the patient who showed the highest decrease of CD4+ cells, moderate genetic diversification of the virus was associated with a biological differentiation. The strain originally presenting two expressed substitutions displayed three more deviations 9 months after the first investigation (including one reversion to the consensus sequence). In addition, the virus that originally could not be cultivated could now be isolated as a low cytopathogenic agent. This study provides evidence that the high genetic homogeneity of HIV-1 observed at the time of seroconversion is maintained as a predominant consensus sequence in the following so-called latent phase of infection.
authors.affiliation: Institute of Medical Microbiology and Immunology, University of Bonn, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Kasper
authors.forename: R
authors.initials: R
authors.lastname: Kaiser
authors.forename: J P
authors.initials: JP
authors.lastname: Kleim
authors.forename: J
authors.initials: J
authors.lastname: Oldenburg
authors.forename: H H
authors.initials: HH
authors.lastname: Brackmann
authors.forename: J
authors.initials: J
authors.lastname: Rockstroh
authors.forename: K E
authors.initials: KE
authors.lastname: Schneweis
mesh_terms: D000595:Amino Acid Sequence; D001483:Base Sequence; D001779:Blood Coagulation Factors / Q000009:adverse effects; D004279:DNA, Viral / Q000235:genetics; D004340:Drug Contamination; D015752:Genes, env; D014644:Genetic Variation; D015658:HIV Infections / Q000150:complications / Q000382:microbiology* / Q000635:transmission; D015497:HIV-1 / Q000235:genetics*; D002836:Hemophilia B / Q000150:complications / Q000188:drug therapy; D006801:Humans; D017386:Sequence Homology, Amino Acid; D012689:Sequence Homology, Nucleic Acid
chemical_list: D001779:Blood Coagulation Factors; D004279:DNA, Viral